Literature DB >> 15053447

The Nijmegen inception cohort of early rheumatoid arthritis.

Paco M J Welsing1, Piet L C M van Riel.   

Abstract

Rheumatoid arthritis is a heterogeneous chronic disease with an unpredictable disease course. To study such a disease, longterm observational studies are needed, with regular assessment of patients using valid and reproducible measures. This article describes the purpose and design of such a study at the Department of Rheumatology, University Medical Centre Nijmegen. Within this inception cohort, several instruments to assess RA were developed and validated, such as the Disease Activity Score, the European League Against Rheumatism response criteria, and a Dutch version of the Health Assessment Questionnaire disability index. These instruments are described and results of studies are discussed concerning prognostic and predictive factors, disease course, and the relationship between the different process and outcome measures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15053447

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  18 in total

1.  Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice.

Authors:  Manathip Osiri; Utis Deesomchok; Peter Tugwell
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

2.  Designing a decision support system for existing clinical organizational structures: considerations from a rheumatology clinic.

Authors:  Orjan Dahlström; Ingrid Thyberg; Ursula Hass; Thomas Skogh; Toomas Timpka
Journal:  J Med Syst       Date:  2006-10       Impact factor: 4.460

3.  The initial validation of a Markov model for the economic evaluation of (new) treatments for rheumatoid arthritis.

Authors:  Paco M J Welsing; Johan L Severens; Margriet Hartman; Anke M van Gestel; Piet L C M van Riel; Roland F J M Laan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases.

Authors:  Alexandra Zhernakova; Behrooz Z Alizadeh; Marianna Bevova; Miek A van Leeuwen; Marieke J H Coenen; Barbara Franke; Lude Franke; Marcel D Posthumus; David A van Heel; Gerrit van der Steege; Timothy R D J Radstake; Pilar Barrera; Bart O Roep; Bobby P C Koeleman; Cisca Wijmenga
Journal:  Am J Hum Genet       Date:  2007-10-24       Impact factor: 11.025

5.  Functional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritis.

Authors:  Theo S Plantinga; Jaap Fransen; Nozomi Takahashi; Rinke Stienstra; Piet L van Riel; Wim B van den Berg; Mihai G Netea; Leo Ab Joosten
Journal:  Arthritis Res Ther       Date:  2010-02-16       Impact factor: 5.156

6.  Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.

Authors:  Toshihiro Matsui; Yoshiaki Kuga; Atsushi Kaneko; Jinju Nishino; Yoshito Eto; Noriyuki Chiba; Masayuki Yasuda; Koichiro Saisho; Kota Shimada; Shigeto Tohma
Journal:  Ann Rheum Dis       Date:  2007-03-16       Impact factor: 19.103

7.  Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.

Authors:  An Tran-Duy; Annelies Boonen; Wietske Kievit; Piet L C M van Riel; Mart A F J van de Laar; Johan L Severens
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

8.  Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples.

Authors:  Cushla McKinney; Manuela Fanciulli; Marilyn E Merriman; Amanda Phipps-Green; Behrooz Z Alizadeh; Bobby P C Koeleman; Nicola Dalbeth; Peter J Gow; Andrew A Harrison; John Highton; Peter B Jones; Lisa K Stamp; Sophia Steer; Pilar Barrera; Marieke J H Coenen; Barbara Franke; Piet L C M van Riel; Tim J Vyse; Tim J Aitman; Timothy R D J Radstake; Tony R Merriman
Journal:  Ann Rheum Dis       Date:  2010-05-14       Impact factor: 19.103

9.  Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.

Authors:  John M Davis; Jaeyun Sung; Benjamin Hur; Vinod K Gupta; Harvey Huang; Kerry A Wright; Kenneth J Warrington; Veena Taneja
Journal:  Arthritis Res Ther       Date:  2021-06-08       Impact factor: 5.156

Review 10.  Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.

Authors:  Tuulikki Sokka; Minja Envalds; Theodore Pincus
Journal:  Mod Rheumatol       Date:  2008-04-25       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.